Circular DNA and DNA/RNA Hybrid Molecules as Scaffolds for Ricin Inhibitor Design
- 7 April 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 129 (17) , 5544-5550
- https://doi.org/10.1021/ja068054h
Abstract
Ricin Toxin A-chain (RTA) catalyzes the hydrolytic depurination of A4324, the first adenosine of the GAGA tetra-loop portion of 28S eukaryotic ribosomal RNA. Truncated stem-loop versions of the 28S rRNA are RTA substrates. Here, we investigate circular DNA and DNA/RNA hybrid GAGA sequence oligonucleotides as minimal substrates and inhibitor scaffolds for RTA catalysis. Closing the 5‘- and 3‘-ends of a d(GAGA) tetraloop creates a substrate with 92-fold more activity with RTA (kcat/Km) than that for the d(GAGA) linear form. Circular substrates have catalytic rates (kcat) comparable to and exceeding those of RNA and DNA stem-loop substrates, respectively. RTA inhibition into the nanomolar range has been achieved by introducing an N-benzyl-hydroxypyrrolidine (N-Bn) transition state analogue at the RTA depurination site in a circular GAGA motif. The RNA/DNA hybrid oligonucleotide cyclic GdAGA provides a new scaffold for RTA inhibitor design, and cyclic G(N-Bn)GA is the smallest tight-binding RTA inhibitor (Ki = 70 nM). The design of such molecules that lack the base-paired stem-loop architecture opens new chemical synthetic approaches to RTA inhibition.Keywords
This publication has 20 references indexed in Scilit:
- Ricin A-Chain Activity on Stem−Loop and Unstructured DNA SubstratesBiochemistry, 2005
- Ricin A-Chain Substrate Specificity in RNA, DNA, and Hybrid Stem−Loop StructuresBiochemistry, 2004
- Inhibition of Ricin A-Chain with Pyrrolidine Mimics of the Oxacarbenium Ion Transition StateBiochemistry, 2004
- Head-to-Tail Oxime Cyclization of Oligodeoxynucleotides for the Efficient Synthesis of Circular DNA AnaloguesThe Journal of Organic Chemistry, 2003
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- The Effect of a Monoclonal Antibody Coupled to Ricin A Chain-Derived Peptides on Endothelial Cells in Vitro: Insights into Toxin-Mediated Vascular DamageExperimental Cell Research, 2000
- Cyclic Oligoribonucleotides (RNA) by Solid-Phase SynthesisChemistry – A European Journal, 1999
- Ricin A-Chain: Kinetics, Mechanism, and RNA Stem−Loop InhibitorsBiochemistry, 1998
- A Network of Heterogeneous Hydrogen Bonds in GNRA TetraloopsJournal of Molecular Biology, 1996
- Ribosomal RNA identity elements for ricin A-chain recognition and catalysisJournal of Molecular Biology, 1992